NEW YORK, NY, Navina, a market leader in AI-powered clinical intelligence, today announced the successful completion of a $55 million Series C funding round, bringing the total funding to $100 million.
The round is led by Growth Equity at Goldman Sachs Alternatives, with participation from existing investors, including Vertex Ventures Israel, Grove Ventures and ALIVE.
Navina's AI copilot brings clinical intelligence to clinicians and care teams, transforming care and value-based outcomes. Navina's powerful AI turns fragmented patient data into a concise patient profile with actionable insights at every clinical touchpoint. Designed for and loved by physicians, Navina reduces missed diagnoses, improves quality metrics and risk adjustment accuracy, and alleviates the administrative burden-allowing providers to focus on what matters most: their patients. Privia Health, agilon health, and Millennium Physician Group are among some of the leading value-based care organizations leveraging Navina's AI copilot to enhance clinician workflows and improve quality performance.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.